Want to join the conversation?
$PFE and Adaptive Biotechnologies announced they have entered into a translational research collaboration to leverage next generation sequencing of adaptive immune system to advance $PFE's immuno-oncology franchise. $PFE and Adaptive will seek to combine drug development and platform technology biomarker expertise for immunotherapy.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.